-

AHF: Funding Global AIDS Response Pays Off, But Fundraising is Difficult

LOS ANGELES--(BUSINESS WIRE)--UNAIDS released a report today, reiterating the many public health, economic, and social benefits of fully funding the global HIV/AIDS response while acknowledging the difficulty of fundraising. AHF supports the authors’ argument that, in addition to mobilizing new resources, there is a need to achieve higher efficiencies in how treatment, retention in care, and prevention and testing services are delivered to people in resource-constrained regions.

“This report reinforces what we already knew – upfront investment in patient-centered HIV care and robust, attractive prevention and testing services has a multiplier effect far beyond health care, including on education attainment by women, productivity among workers, the financial security of households, and much more,” said AHF Chief of Global Advocacy and Policy Terri Ford.

AHF Africa Bureau Chief Dr. Penninah Iutung added, “The investment case is compelling, but the reality must also be acknowledged: Where will the additional billions of dollars come from? Now, UNAIDS must become the chief resource mobilization advocate and technical advisor to work with countries on developing realistic financing action plans. It will take significant political will and a combination of strategies to improve efficiencies, increase domestic financing, and convince donors that the upfront investment is well worth the cost. We hope this report is just the first step for UNAIDS.”

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1 323.308.1833 work
+1 323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org

AIDS Healthcare Foundation


Release Versions
Hashtags

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1 323.308.1833 work
+1 323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org

More News From AIDS Healthcare Foundation

AHF: Florida Lawmakers Reverse HIV Drug Cuts, Restoring Coverage for Thousands

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Thousands of Floridians living with HIV will keep the medication that keeps them alive, after the Florida Legislature today passed a state budget that reverses this year's cuts to the AIDS Drug Assistance Program (ADAP). The budget returns eligibility to 400 percent of the federal poverty level, brings back the medications the Department of Health had dropped, including Biktarvy, funds the program with $75 million, and adds independent oversight. "This is wha...

AHF Calls for Access and Dignity on Menstrual Health Day

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) joins the global commemoration of Menstrual Health Day with events across nearly 50 countries, highlighting the importance of reducing period stigma and expanding access to affordable menstrual products—critical steps in protecting overall health and reducing vulnerability to HIV and other sexually transmitted infections. Menstrual Health Day is observed annually on May 28. Around the world, barriers to menstrual health continue to...

Ebola Crisis Exposes Failure of Current Global Health Architecture, says AHF

LOS ANGELES--(BUSINESS WIRE)--As Uganda and the Democratic Republic of the Congo (DRC) confront a rapidly evolving Ebola outbreak, AIDS Healthcare Foundation (AHF) warns that the crisis highlights persistent weaknesses in the world’s ability to respond quickly and equitably to emerging infectious disease threats. The current outbreak involves the Bundibugyo strain of Ebola virus, for which no approved vaccines or therapeutics currently exist, heightening concerns among global health officials a...
Back to Newsroom